[Elsevier] Efficacy and safety of branebrutinib (BMS-986195), an irreversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2a, randomised, double-blind, placebo-controlled study |
|
This post will be closed automatically in 2026-06-30 19:02
Best Answer
1 hour(s) ago
|
| |
20
Construction of high-performance NiCe-MOF derived structured catalyst for steam reforming of biomass tar model compound
10
A systematic review of cognitive failures in daily life: Healthy populations
10
A novel solar hydrogen production system integrating high temperature electrolysis with ammonia based thermochemical energy storage
10
Vitamines en neurologie: la vitamine E
30
LANCET - Intermittent fasting to treat diabetes: time to update clinical practice guidelines
